- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Alcedis GmbH
Total 3348 results
-
Fresenius Medical Care Deutschland GmbHAlcedis GmbHRecruiting
-
Fresenius Medical Care Deutschland GmbHAlcedis GmbHRecruitingRenal Failure | End Stage Renal Disease | Acute Renal FailureGermany
-
Scandion Oncology A/SAlcedis GmbHRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Inoperable Disease | Localized Pancreatic AdenocarcinomaDenmark, Germany
-
Allarity TherapeuticsAmarex Clinical Research; Alcedis GmbHRecruitingAdvanced Ovarian CancerUnited Kingdom, United States
-
Kinderkrankenhaus auf der BultAstraZeneca; Alcedis GmbHCompleted
-
Valentina PuentmannBayer; Alcedis GmbHRecruitingMicrovascular Angina | Left Ventricular Dysfunction | Vascular Inflammation | Exercise Intolerance | Remodeling, Left Ventricle | Remodeling, Vascular | COVID-19 Associated Cardiac InvolvementGermany, Austria
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
R-PharmAlmedisCompleted
-
R-PharmAlmedisCompletedChronic Hepatitis C Genotype 1bRussian Federation
-
AbbottAlmedisCompletedHeadache Disorders, Primary | Tension-Type Headache | Migraine Without Aura | Migraine With AuraKazakhstan, Ukraine
-
R-PharmAlmedisCompletedHealthyRussian Federation
-
AIO-Studien-gGmbHServier Deutschland GmbH; Crolll GmbhActive, not recruitingMetastatic Pancreatic Cancer | Locally Advanced Pancreatic CancerGermany
-
VisionHealth GmbHThoraxklinik-Heidelberg gGmbHRecruiting
-
Aleris EyeRecruiting
-
Aleris HospitalActive, not recruitingPostoperative Complications | Metabolic Syndrome | Obesity, Morbid | Bariatric Surgery CandidateNorway
-
Algenis SpAOncoclínicasRecruitingChemotherapy-induced Peripheral NeuropathyBrazil
-
Algenis SpACompletedBack Pain | Acute PainChile
-
AIO-Studien-gGmbHPfizer; Crolll GmbhRecruitingRenal Cell Carcinoma, Metastatic | Renal Cell Cancer, RecurrentGermany
-
AIO-Studien-gGmbHCelgene; ClinAssess GmbHCompletedResectable Pancreatic Cancer | Ductal Adenocarcinoma of the PancreasGermany
-
Thoraxklinik-Heidelberg gGmbHErbe Elektromedizin GmbHCompletedTransbronchial CryobiopsyGermany
-
AIO-Studien-gGmbHSanofi; ClinAssess GmbHTerminatedBreast Cancer | Lung Cancer | Recurrent Brain Metastases | Progressive Brain MetastasesGermany
-
AbbVie (prior sponsor, Abbott)AlmedisCompleted
-
AIO-Studien-gGmbHAmgen; ClinAssess GmbHCompletedMetastatic Colorectal CancerGermany
-
AIO-Studien-gGmbHAmgen; ClinAssess GmbHCompleted
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Ascendis Pharma Bone Diseases A/SActive, not recruitingEndocrine System Diseases | Parathyroid Diseases | HypoparathyroidismUnited States, Canada, Norway, Denmark, Germany, Hungary, Italy
-
Ascendis Pharma Endocrinology Division A/SCompletedEndocrine System Diseases | Pituitary Diseases | Hormones | Growth Hormone Deficiency, Pediatric | hGH (Human Growth Hormone)United States, Armenia, Australia, Belarus, Bulgaria, Georgia, Greece, Italy, New Zealand, Poland, Romania, Russian Federation, Turkey, Ukraine
-
Ascendis Pharma A/SCompletedAdult Growth Hormone DeficiencySweden, Denmark, Germany, Italy
-
Ascendis Pharma A/SCompletedGrowth Hormone Deficiency (GHD)Egypt, Turkey, Germany, Poland, France, Hungary, Russian Federation, Ukraine, Belarus, Bulgaria, Czech Republic, Greece, Romania, Slovenia
-
WiSP Wissenschaftlicher Service Pharma GmbHMundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbHCompletedChronic Lymphocytic LeukemiaGermany
-
Aleris HelseCompletedPerioperative/Postoperative ComplicationsNorway
-
Aleris ObesityCompletedWeight Loss | Morbid ObesitySweden
-
AIO-Studien-gGmbHMerck Serono GmbH, GermanyTerminatedCholangiocarcinoma | Biliary Tract CancerGermany
-
AIO-Studien-gGmbHCelgene Corporation; ClinAssess GmbHCompletedAdenocarcinoma of the Pancreas | Metastatic Pancreatic CancerGermany
-
AIO-Studien-gGmbHCelgene Corporation; ClinAssess GmbHCompletedDuctal Adenocarcinoma of the PancreasGermany
-
Algenis SpACovanceCompleted
-
AlcisNot yet recruiting
-
AlcisCompleted
-
AbbVie (prior sponsor, Abbott)AlmedisCompleted
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
Infectopharm Arzneimittel GmbHGesellschaft für Therapieforschung mbHRecruitingAtopic Dermatitis | Infant, NewbornGermany
-
Infectopharm Arzneimittel GmbHGesellschaft für Therapieforschung mbHCompletedActinic KeratosisGermany
-
Infectopharm Arzneimittel GmbHGesellschaft für Therapieforschung mbHCompleted
-
Ascendis Pharma Growth Disorders A/SRecruitingAchondroplasiaUnited States, Australia
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
Ascendis Pharma Growth Disorders A/SEnrolling by invitationAchondroplasiaUnited States, Australia, Denmark, Ireland, Austria, Germany, New Zealand
-
Ascendis Pharma Endocrinology Division A/SCompletedEndocrine System Diseases | Growth Hormone Deficiency | Hormone DeficiencyUnited States, Armenia, Georgia, Turkey, Ukraine, Australia, Canada, Denmark, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Romania, Serbia, Slovakia, Spain, United Kingdom
-
Aleris HelseNovartisCompletedCentral Retinal Vein Occlusion | Macular EdemaNorway
-
Ascendis Pharma Oncology Division A/SRecruitingHead and Neck NeoplasmsUnited States, Spain, Georgia, Italy, Hungary, Germany
-
Ascendis Pharma Endocrinology Division A/SRecruitingGrowth Hormone DeficiencyUnited States